Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

445.12
+15.323.56%
Post-market: 445.12-0.1240-0.03%18:14 EST
Volume:908.16K
Turnover:402.50M
Market Cap:58.81B
PE:1.35K
High:447.69
Open:432.87
Low:430.27
Close:429.80
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:0.79
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3299
EPS(LYR):-2.1790
ROE:32.73%
ROA:3.65%
PB:251.42
PE(LYR):-204.27

Loading ...

Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2025

Correspondence

Form CORRESP - Correspondence